Detalhe da pesquisa
1.
Hemoglobin and End-Organ Damage in Individuals with Sickle Cell Disease.
Curr Ther Res Clin Exp
; 98: 100696, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36950457
2.
What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study.
Br J Haematol
; 194(2): 463-468, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34131902
3.
Opioid utilization patterns in United States individuals with sickle cell disease.
Am J Hematol
; 93(10): E345-E347, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30051929
4.
Cognition and education benefits of increased hemoglobin and blood oxygenation in children with sickle cell disease.
PLoS One
; 18(8): e0289642, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37552696
5.
Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study.
Biomed Res Int
; 2023: 7533111, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748060
6.
Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient.
Transplant Cell Ther
; 29(10): 637.e1-637.e9, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37364775
7.
Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients.
Nephrol Dial Transplant
; 27(6): 2418-25, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22187314
8.
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis.
Expert Rev Hematol
; 15(2): 167-173, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191358
9.
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Haematol
; 8(5): e323-e333, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33838113
10.
Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis.
PLoS One
; 15(4): e0229959, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32243480
11.
The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims Study.
J Manag Care Spec Pharm
; 26(9): 1121-1129, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32597290
12.
Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.
JAMA Netw Open
; 2(11): e1915374, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31730182
13.
Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease.
Hematol Rep
; 10(2): 7643, 2018 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30046415
14.
Patient-Reported Outcomes in Chronic Heart Failure: Applicability for Regulatory Approval.
JACC Heart Fail
; 4(10): 791-804, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27395351
15.
Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective.
J Osteoporos
; 2015: 627631, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26783494
16.
Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate.
J Clin Endocrinol Metab
; 100(3): E487-92, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25514106
17.
Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States.
Mayo Clin Proc
; 90(1): 53-62, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25481833
18.
A systematic review of osteoporosis medication adherence and osteoporosis-related fracture costs in men.
Appl Health Econ Health Policy
; 12(3): 267-77, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24477429
19.
The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type.
J Med Econ
; 16(1): 43-54, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22954063
20.
Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure.
Circ Heart Fail
; 5(6): 672-9, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23072736